Consensus QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 20:01:27 09/07/2025 BST			5-day change	1st Jan Change
31.14 ^USD	+1.04%		+2.78%	-30.37%

07-07	QuidelOrtho Corporation Announces Management Appointments	CI
07-07	Quidelortho strengthens leadership team with appointments of senior vice presidents for global quality and clinical & regulatory affairs	RE

Evolution of the Average Target: QuidelOrtho Corporation

Evolution of the Target Price: QuidelOrtho Corporation

Changes in Analyst Recommendations: QuidelOrtho Corporation

05e1.40XN6y7ew0KzBSZdPeiBovWv11-_NTvCNdvpQi53Yaw.jgP6u37sqwr6fHYSXNjR-5bamG3PUXKKYKiEBm84CYGFNZmCcayRNuYyEg~a9da85008dffcaadaf03b2f2fe8178f6

Analysts' recommendations: QuidelOrtho Corporation

UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating	05-08	MT
UBS Raises Price Target on QuidelOrtho to $45 From $43, Maintains Neutral Rating	02-13	MT
RBC Trims Price Target on QuidelOrtho to $61 From $64, Keeps Outperform Rating	02-13	MT
Citigroup Upgrades QuidelOrtho to Buy From Neutral, Raises Price Target to $50 From $44	12-11	MT
Jefferies Initiates QuidelOrtho at Hold With $43 Price Target	12-10	MT
UBS Cuts Price Target on QuidelOrtho to $43 From $50, Maintains Neutral Rating	11-08	MT
RBC Capital Adjusts QuidelOrtho Price Target to $64 From $62, Maintains Outperform Rating	11-08	MT
UBS Upgrades QuidelOrtho to Neutral From Sell, Adjusts Price Target to $50 From $42	19/09/24	MT
RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating	13/09/24	MT
Craig-Hallum Upgrades QuidelOrtho to Buy From Hold, Adjusts Price Target to $57 From $40	05/09/24	MT
RBC Cuts Price Target on QuidelOrtho to $61 From $68, Keeps Outperform Rating	24/06/24	MT
RBC Cuts Price Target on QuidelOrtho to $68 From $81, Keeps Outperform Rating	09/05/24	MT
UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	04/03/24	MT
William Blair Downgrades QuidelOrtho to Market Perform From Outperform	14/02/24	MT
Citigroup Adjusts Price Target on QuidelOrtho to $50 From $72, Maintains Neutral Rating	14/02/24	MT
Craig-Hallum Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $50 From $158	14/02/24	MT
Raymond James Downgrades QuidelOrtho to Outperform From Strong Buy, Cuts Price Target to $76 From $100	14/02/24	MT
JPMorgan Downgrades QuidelOrtho to Underweight From Neutral, Adjusts Price Target to $37 From $66	14/02/24	MT
RBC Adjusts PT on QuidelOrtho to $81 From $130, Notes Worse-Than-Anticipated COVID Headwinds; Outperform Kept on 'Compelling' Risk/Reward	14/02/24	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $140, Keeps Outperform Rating	21/12/23	MT
Citigroup Downgrades QuidelOrtho to Neutral From Buy, Cuts Price Target to $72 From $95	11/12/23	MT
Raymond James Adjusts QuidelOrtho's Price Target to $110 From $130, Keeps Strong Buy Rating	15/08/23	MT
RBC Raises QuidelOrtho's Price Target to $136 From $133, Keeps Outperform Rating	17/07/23	MT
UBS Adjusts QuidelOrtho Price Target to $98 From $99, Maintains Neutral Rating	17/05/23	MT
RBC Boosts Price Target on QuidelOrtho to $133 From $130, Maintains Outperform Rating	04/05/23	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Ecart obj. / dr
QUIDELORTHO CORPORATION				+52.96%
SARTORIUS AG				+17.1%
SHANGHAI MICROPORT EP MEDTECH CO., LTD.				+25.75%
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.			-	-
BIOTAGE AB	-	-	-	-
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.				+20.61%
REVENIO GROUP OYJ				+10.62%
CELLAVISION AB				+25.6%
VAREX IMAGING CORPORATION				+96.92%
Average				+35.65%
Weighted average by Cap.				+22.31%